Descrizione business
Spectrum Pharmaceuticals is a leading biotechnology company focused on acquiring, developing, and commercializing drug products, with a primary focus in Hematology and Oncology. Spectrum currently markets five hematology/oncology drugs, and expects an FDA decision on another hematology drug later this year. Additionally, Spectrum's pipeline includes three drugs targeting blockbuster markets in advanced stages of clinical development. Spectrum's strong track record for in-licensing and acquiring differentiated drugs, and expertise in clinical development have generated a robust, diversified, and growing pipeline of product candidates in advanced-stage Phase 2 and Phase 3 studies.
Consiglio di amministrazione & Consiglio di sorveglianza
| CEO |
| Joseph Turgeon |
| Consiglio di amministrazione |
| Kurt Gustafson, Francois Lebel, Keith M. McGahan, Thomas J. Riga |
| Consiglio di sorveglianza |
| William L. Ashton, Bernice R. Welles, Dolatrai M. Vyas, Jeffrey L. Vacirca, Joseph W. Turgeon, Nora Brennan, Seth H.Z. Fischer |
Dati aziendali
| Name: |
Spectrum Pharmaceuticals Inc. |
| Indirizzo: |
11500 S. Eastern Avenue, Suite 240,Henderson, NV 89052, USA |
| Telefono: |
+1-702-935-6300 |
| Fax: |
+1-702-260-7405 |
| E-mail: |
-
|
| Internet: |
https://www.sppirx.com/ |
| Industria: |
Biotechnology |
| Settore: |
Biotechnology |
| Sub settore: |
Biotechnology |
| Fine dell'anno finanziario: |
31/12 |
| Flottante libero: |
61.22% |
| Data dell'IPO: |
- |
Rapporti con gli investitori
| Name: |
Shiv Kapoor |
| IR telefono: |
- |
| IR Fax: |
- |
| IR e-mail: |
IR@sppirx.com
|
